1. Acute kidney injury cases with ciprofloxacin + enalapril

   News item 10 March 2018 Pages: 1 - 1

2. Canadian labelling updates for Alcaine, Concerta, Zoloft

   News item 10 March 2018 Pages: 2 - 2

3. Chinese herbal medicine contains undisclosed ingredients

   News item 10 March 2018 Pages: 3 - 3

4. No link between use of ruxolitinib and liver injury

   News item 10 March 2018 Pages: 4 - 4

5. Serious neurological adverse events with ivermectin

   News item 10 March 2018 Pages: 5 - 5

6. UK's MHRA warning to check Aquilon nebulisers for CE mark

   News item 10 March 2018 Pages: 6 - 6

7. US FDA warns of heart issues, death with clarithromycin

   News item 10 March 2018 Pages: 7 - 7

8. Balanced crystalloids safer than saline?

   Clinical study 10 March 2018 Pages: 8 - 8

9. Calcium channel blockers increase risk of lung cancer

   Clinical study 10 March 2018 Pages: 9 - 9

10. Most common AE reported to FAERS is drug ineffective

    Clinical study 10 March 2018 Pages: 10 - 10

11. Safety of medicinal plant use in warfarin recipients

    Clinical study 10 March 2018 Pages: 11 - 11

12. Sex differences in SSRI adverse reactions

    Clinical study 10 March 2018 Pages: 12 - 12

13. Abacavir/dolutegravir/lamivudine

    Case report 10 March 2018 Pages: 13 - 13

14. Abiraterone-acetate/prednisolone

    Case report 10 March 2018 Pages: 14 - 14

15. Acenocoumarol/dabigatran etexilate

    Case report 10 March 2018 Pages: 15 - 15

16. Adalimumab

    Case report 10 March 2018 Pages: 16 - 16

17. Adalimumab

    Case report 10 March 2018 Pages: 17 - 17

18. Adalimumab

    Case report 10 March 2018 Pages: 18 - 18

19. Adalimumab

    Case report 10 March 2018 Pages: 19 - 19

20. Adalimumab/dexamethasone/etoposide

    Case report 10 March 2018 Pages: 20 - 20

21. Adalimumab/infliximab/tofacitinib

    Case report 10 March 2018 Pages: 21 - 21

22. Afatinib

    Case report 10 March 2018 Pages: 22 - 22

23. Afatinib

    Case report 10 March 2018 Pages: 23 - 23

24. Aflibercept

    Case report 10 March 2018 Pages: 24 - 24

25. Ajmaline

    Case report 10 March 2018 Pages: 25 - 25

26. Alemtuzumab

    Case report 10 March 2018 Pages: 26 - 26

27. Alendronic-acid

    Case report 10 March 2018 Pages: 27 - 27

28. Alglucosidase-alfa

    Case report 10 March 2018 Pages: 28 - 28

29. Allopurinol

    Case report 10 March 2018 Pages: 29 - 29

30. Allopurinol/febuxostat

    Case report 10 March 2018 Pages: 30 - 30

31. Alteplase

    Case report 10 March 2018 Pages: 31 - 31

32. Amiodarone/β-adrenergic-receptor-antagonists

    Case report 10 March 2018 Pages: 32 - 32

33. Amisulpride/codeine/grindelia camporum/guaiacolsulfonic acid

    Case report 10 March 2018 Pages: 33 - 33

34. Amlodipine/ziyin huoxue fang

    Case report 10 March 2018 Pages: 34 - 34

35. Amoxicillin

    Case report 10 March 2018 Pages: 35 - 35

36. Amoxicillin

    Case report 10 March 2018 Pages: 36 - 36

37. Amphotericin B liposomal

    Case report 10 March 2018 Pages: 37 - 37

38. Anti-D-Rh0-immunoglobulin

    Case report 10 March 2018 Pages: 38 - 38

39. Antidepressants

    Case report 10 March 2018 Pages: 39 - 39

40. Antiemetics/loperamide abuse

    Case report 10 March 2018 Pages: 40 - 40

41. Antiepileptic drugs

    Case report 10 March 2018 Pages: 41 - 41

42. Antifungals/ciclosporin

    Case report 10 March 2018 Pages: 42 - 42

43. Antihypertensives

    Case report 10 March 2018 Pages: 43 - 43

44. Antineoplastics

    Case report 10 March 2018 Pages: 44 - 44

45. Antineoplastics

    Case report 10 March 2018 Pages: 45 - 45

46. Antineoplastics/doxorubicin

    Case report 10 March 2018 Pages: 46 - 46

47. Antineoplastics/ethiodized oil/gelatin

    Case report 10 March 2018 Pages: 47 - 47

48. Antithymocyte globulin/busulfan/cyclophosphamide

    Case report 10 March 2018 Pages: 48 - 48

49. Antivirals

    Case report 10 March 2018 Pages: 49 - 49

50. Antivirals

    Case report 10 March 2018 Pages: 50 - 50